Drug naive or newly diagnosed type 2 diabetic subjects:

Never received oral antihyperglycemic or insulin therapy or

No oral antihyperglycemic or insulin therapy for more than 6 months since original diagnosis and

No insulin therapy within one year of screening, with the exception of use during hospitalization or for use in gestational diabetes and

No antihyperglycemic therapy for more than three consecutive days, or a total of of seven non-consecutive days, during the 8 weeks prior to screening.

HbA1C\>6.7% and \< or = to 10% at screening

Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917

What this study is about